Nasdaq Prtk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Perkins Capital Management Inc. lowered its position in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Free Report) by 70.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,700 shares of the specialty pharmaceutical company’s stock after selling 32,000 shares during the quarter. Perkins […]

StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also recently weighed in on PRTK. Jefferies Financial Group cut Paratek Pharmaceuticals from a buy rating to […]

BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (

StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report released on Thursday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of a number of other reports. HC Wainwright reissued a neutral rating and set a $2.15 price objective on […]

StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of several other research reports. HC Wainwright reiterated a neutral rating and issued a $2.15 target […]